文献速递神经MR

高级别胶质瘤的主要基因差异可能呈现不同的MR成像与MR波谱关联

Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates.
PubMed 文献 · Eur Radiol · 2020-09-01

研究纳入79例组织学确诊的高级别胶质瘤患者,分析IDH1、ATRX、Ki-67、p53与MR成像及波谱特征的关联。IDH1野生型肿瘤移动脂质更高(p=0.001),p53未表达者浸润模式更明显(p=0.009),ATRX突变者谷氨酸+谷氨酰胺(Glx)更高(p=0.001)。IDH1状态、年龄和肿瘤胆碱水平为独立生存预后因素。

要点

  • IDH1野生型高级别胶质瘤的移动脂质水平高于IDH1突变型(p=0.001)。
  • p53未表达的高级别胶质瘤更易呈现浸润性生长模式(p=0.009)。
  • ATRX突变型肿瘤的谷氨酸+谷氨酰胺(Glx)水平更高(p=0.001)。

核心结论

  • 结果提示IDH1野生型肿瘤比IDH1突变型更富坏死。
  • 高级别胶质瘤出现浸润模式与p53表达缺失、Ki-67指数及Glx水平相关。
  • 肿瘤胆碱水平可作为IDH1状态之外的生存预测因素,以更准确预测高级别胶质瘤患者生存。

研究设计与样本

  • 研究类型为影像-分子关联分析,纳入79例组织学确诊的高级别胶质瘤患者。
  • 采用免疫组化分析IDH1、ATRX、Ki-67及p53蛋白表达。
  • 在MR图像上评估肿瘤影像学特征,并用MR波谱评估代谢谱与浸润模式。
  • 采用Kaplan-Meier法和Cox回归模型分析生存预后因素。

关键影像表现/征象

  • IDH1野生型肿瘤的移动脂质水平高于IDH1突变型(p=0.001)。
  • p53未表达的高级别胶质瘤浸润模式更明显(p=0.009)。
  • ATRX突变型肿瘤的谷氨酸和谷氨酰胺(Glx)水平更高(p=0.001)。
  • Glx水平(p=0.038)与Ki-67表达(p=0.008)均与浸润模式存在关联。

诊断标准与关键数值

  • 79例中IDH1突变占17.7%,ATRX突变占8.9%,p53未表达占70.9%,Ki-67>5%占22.8%。
  • 生存分析确定IDH1状态、年龄和肿瘤胆碱水平为独立预后预测因素。

临床应用与阅片要点

  • 作者认为肿瘤胆碱水平可联合IDH1状态用于更准确预测高级别胶质瘤患者生存。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess whether the main genetic differences observed in high-grade gliomas (HGG) will present different MR imaging and MR spectroscopy correlates that could be used to better characterize lesions in the clinical setting.

METHODS: Seventy-nine patients with histologically confirmed HGG were recruited. Immunohistochemistry analyses for isocitrate dehydrogenase gene 1 (IDH1), alpha thalassemia mental retardation X-linked gene (ATRX), Ki-67, and p53 protein expression were performed. Tumour radiological features were examined on MR images. Metabolic profile and infiltrative pattern were assessed with MR spectroscopy. MR features were analysed to identify imaging-molecular associations. The Kaplan-Meier method and the Cox regression model were used to identify survival prognostic factors.

RESULTS: In total, 17.7% of the lesions were IDH1-mutated, 8.9% presented ATRX-mutated, 70.9% presented p53 unexpressed, and 22.8% had Ki-67 > 5%. IDH1 wild-type tumours had higher levels of mobile lipids (p = 0.001). The tumour-infiltrative pattern was higher in HGG with unexpressed p53 (p = 0.009). Mutated ATRX tumours presented higher levels of glutamate and glutamine (Glx) (p = 0.001). An association was observed between Glx tumour levels (p = 0.038) and Ki-67 expression (p = 0.008) with the infiltrative pattern. Survival analyses identified IDH1 status, age, and tumour choline levels as independent predictors of prognostic significance.

CONCLUSIONS: Our results suggest that IDH1-wt tumours are more necrotic than IDH1-mut. And that the presence of an infiltrative pattern in HGG is associated with loss of p53 expression, Ki-67 index, and Glx levels. Finally, tumour choline levels could be used as a predictive factor in survival in addition to the IDH1 status to provide a more accurate prediction of survival in HGG patients.

KEY POINTS: • IDH1-wt tumours present higher levels of mobile lipids than IDH1-mut. • Mutated ATRX tumours exhibit higher levels of glutamate and glutamine. • Loss of p53 expression, Ki-67 expression, and glutamate and glutamine levels may contribute to the presence of an infiltrative pattern in HGG.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bernabéu-Sanz Á, Fuentes-Baile M, Alenda C, et al. Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates. Eur Radiol. 2020. PMID: 32875375. doi:10.1007/s00330-020-07138-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。